Moro JA - Search Results

1

Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation.

Aguero J, Almenar L, Martínez-Dolz L, Moro JA, Rueda J, Raso R, Chamorro C, Sanchez JM, Salvador A. Aguero J, et al. Among authors: moro ja. Clin Transplant. 2008 Jan-Feb;22(1):98-106. doi: 10.1111/j.1399-0012.2007.00751.x. Clin Transplant. 2008. PMID: 18217910

2

Natriuretic peptides and heart transplant.

Almenar L, Martínez-Dolz L, Moro J. Almenar L, et al. Curr Opin Mol Ther. 2007 Jun;9(3):282-90. Curr Opin Mol Ther. 2007. PMID: 17608027 Review.

3

Prognostic relationship between two serial determinations of B-type natriuretic peptide and medium-long-term events in heart transplantation.

Martínez-Dolz L, Almenar L, Hervás I, Moro J, Agüero J, Sánchez-Lázaro I, Mateo A, Salvador A. Martínez-Dolz L, et al. J Heart Lung Transplant. 2008 Jul;27(7):735-40. doi: 10.1016/j.healun.2008.04.008. Epub 2008 Jun 2. J Heart Lung Transplant. 2008. PMID: 18582802

4

Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A. Martínez-Dolz L, et al. J Heart Lung Transplant. 2008 Jul;27(7):760-6. doi: 10.1016/j.healun.2008.04.010. Epub 2008 Jun 6. J Heart Lung Transplant. 2008. PMID: 18582806

5

Do cardiovascular risk factors influence cardiac allograft vasculopathy?

Chamorro CI, Almenar L, Martínez-Dolz L, Sánchez-Lacuesta E, Martín-Pastor J, Ten-Morro F, Sánchez-Soriano RM, Agüero J, Ortiz V, Moro JA, Salvador A. Chamorro CI, et al. Among authors: moro ja. Transplant Proc. 2006 Oct;38(8):2572-4. doi: 10.1016/j.transproceed.2006.08.034. Transplant Proc. 2006. PMID: 17098006

6

Randomized prospective study of the evolution of renal function depending on the anticalcineurin used.

Moro JA, Almenar Bonet L, Martínez-Dolz L, Raso R, Sánchez-Lázaro I, Agüero J, Salvador A. Moro JA, et al. Transplant Proc. 2008 Nov;40(9):2906-8. doi: 10.1016/j.transproceed.2008.08.117. Transplant Proc. 2008. PMID: 19010143 Clinical Trial.

7

Clinical variables associated with the presence of inflammatory infiltrates in patients with dilated cardiomyopathy undergoing heart transplantation.

Agüero J, Navarro J, Medina MC, Almenar L, Chirivella M, Martínez-Dolz L, Moro JA, Sánchez-Lazaro I, Ortiz V, Raso R, Salvador A. Agüero J, et al. Among authors: moro ja. Transplant Proc. 2008 Nov;40(9):3017-9. doi: 10.1016/j.transproceed.2008.09.010. Epub 2008 Oct 11. Transplant Proc. 2008. PMID: 19010177

8

Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation.

Moro JA, Almenar L, Martínez-Dolz L, Sánchez-Lázaro I, Agüero J, Salvador A. Moro JA, et al. Transplant Proc. 2008 Nov;40(9):3034-6. doi: 10.1016/j.transproceed.2008.09.049. Transplant Proc. 2008. PMID: 19010183

9

Support program for heart transplant patients: initial experience.

Moro JA, Almenar L, Martńez-Dolz L, Agüero J, Sánchez-Lázaro I, Iglesias P, Igual V, Salvador A. Moro JA, et al. Transplant Proc. 2008 Nov;40(9):3039-40. doi: 10.1016/j.transproceed.2008.08.101. Transplant Proc. 2008. PMID: 19010185

10

Utility of oral valganciclovir for cytomegalovirus prophylaxis: does it improve treatment compliance?

Moro JA, Almenar L, Martínez-Dolz L, Blanes M, Agüero J, Sánchez-Lázaro I, Salvador A. Moro JA, et al. Transplant Proc. 2008 Nov;40(9):3063-4. doi: 10.1016/j.transproceed.2008.09.052. Transplant Proc. 2008. PMID: 19010195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters